Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
South Korean researchers found no difference in the rates of liver cancer, liver transplant or death based on the treatment used.
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Researchers analyzed autopsies among people with HIV who died in New York City since 1984.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
Researchers have presented findings from the first large cohort of people followed over a lengthy period to assess this connection.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
An analysis conducted in Taiwan analyzed health outcomes over more than a decade.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
The drug is still associated with a lower liver cancer rate than Baraclude.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
Opioid overdoses kill more Americans than car crashes, drowning, fire, and falls.
One researcher argues that the pharmaceutical industry ought to pay greater heed to such risks during drug development.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.